MedCompanion

Necrotizing Soft-Tissue Infection

SSTI

Source: IDMP View on spectrum chart →
Patient + scenario modifiers
Patient
Clinical scenario / source

Annotations only — chart still shows the full chemistry of each drug.

1. Clinical Syndrome

Rapidly progressive infection of subcutaneous tissue and/or fascia (occasionally muscle) with tissue necrosis and systemic toxicity. Surgical emergency — antibiotics never substitute for emergent operative debridement.

Microbiologic types:

  • Type I — polymicrobial (~70%): mix of GNR + GPC + anaerobes (incl. B. fragilis); diabetics, post-operative, GU/perineal (Fournier gangrene).
  • Type II — monomicrobial: Group A streptococcus (S. pyogenes) most classic; can also be S. aureus (incl. MRSA). Healthy hosts, often after minor trauma. Streptococcal toxic shock syndrome (TSS) frequent.
  • Type III — water-associated: Vibrio vulnificus (saltwater, raw oysters, cirrhosis/iron overload) or Aeromonas hydrophila (freshwater).
  • Type IV — fungal: rare, post-traumatic in immunocompromised; mucormycosis usually.

Clostridial myonecrosis (gas gangrene) — C. perfringens primarily; deep muscle involvement, crepitus, severe pain out of proportion. Treated with same urgent surgical + antibiotic principles; toxin suppression with clindamycin essential.

Excludes: uncomplicated cellulitis without necrosis (see non-purulent cellulitis syndrome), purulent abscess without fascial involvement (see purulent SSTI), pyomyositis without fascial necrosis.

2. Pathogens

Consider the patient: Diabetes, immunocompromise, IVDU, chronic liver disease (esp Vibrio risk with seafood / saltwater exposure), recent surgery, IV drug use, malignancy.

Consider the case: Water exposure (Vibrio / Aeromonas), perineal / GU source (Fournier — polymicrobial), recent surgery (polymicrobial + healthcare flora), young healthy patient after minor trauma (Group A strep), deep crepitus + brown drainage + sweet odor (Clostridium).

Red flags: pain out of proportion to exam, rapid progression, systemic toxicity disproportionate to skin findings, crepitus, skin necrosis / bullae, anesthesia over the involved area (sensory nerve destruction).

Common

Less common

3. Empiric Therapy

TierFirst choiceAlternativesDurationComments
ICU — Pseudomonas risk
  • load + AUC-guided · — · IV
  • 4.5 g · q6h (extended infusion) · IV
  • 900 mg · q8h · IV

    **Adjunctive toxin suppression** — give until 48–72 h after clinical stabilization; do not omit even if cultures grow only gram-negatives.

  • Vanc + meropenem + clindamycin — · — · IV

    ESBL / severe / immunocompromised. Meropenem replaces pip-tazo.

2–3 weeks total (longer if abscess, retained necrotic tissue, persistent bacteremia). Narrow on cultures + surgical findings.**Empiric for all suspected necrotizing infection.** Vanc covers MRSA; pip-tazo covers GNR + anaerobes; clinda suppresses streptococcal + clostridial exotoxin. **Emergent surgical consult / OR for debridement is the priority** — never delay for imaging if clinical suspicion is high.
Admitted to ICU
  • 100 mg · q12h · IV/PO
  • 2 g · q24h · IV
  • 400 mg · q12h · IV

    Plus doxycycline. Monotherapy with cipro acceptable in some guidelines but combo preferred.

1–2 weeks after source control**Vibrio vulnificus suspected** — saltwater exposure / raw oysters / cirrhotic / hemochromatosis. Combine doxycycline + ceftriaxone (IDSA preferred). For Aeromonas (freshwater) similar combo. Emergent surgical debridement still essential.

Add coverage if:

MRSA coverage
  • IVDU
  • Prior MRSA
  • Healthcare-associated
  • Severe / monomicrobial S. aureus

Add:

  • load + AUC-guided · — · IV
Vibrio coverage
  • Saltwater exposure
  • Raw oyster / shellfish ingestion
  • Cirrhosis / hemochromatosis / iron overload
  • Rapid bullae + skin necrosis in coastal patient

Add:

  • 100 mg · q12h · IV/PO
  • 2 g · q24h · IV

    Combination is IDSA-preferred.

Clostridium coverage
  • Crepitus + brown / sweet-smelling drainage
  • Gas in soft tissues on imaging
  • Penetrating injury / contaminated wound
  • Severe pain out of proportion

Add:

  • 4 million units · q4h · IV
  • 900 mg · q8h · IV

    Toxin suppression — essential. Don't drop clinda after cultures even if PCN sufficient on susceptibility.

4. Directed Therapy

SURGICAL DEBRIDEMENT IS THE TREATMENT. Antibiotics are adjuncts. Operative findings (color, consistency, gas, fascial necrosis) confirm diagnosis. Plan for repeat OR every 24–48 h until no further necrosis.

Adjuncts:

  • Clindamycin for toxin suppression in any suspected streptococcal or clostridial disease — Eagle effect: high inoculum makes β-lactams ineffective via 'inoculum effect'; clinda inhibits protein (toxin) synthesis even at stationary phase.
  • IVIG for streptococcal toxic shock syndrome (1 g/kg day 1, 0.5 g/kg days 2–3) — adjunctive; evidence modest but reasonable in severe disease.
  • Hyperbaric oxygen — controversial for clostridial myonecrosis; case-by-case.

Source-specific directed therapy:

  • Group A strep monomicrobial: PCN-G 4 MU q4h + clindamycin 900 mg q8h × 14 days. De-escalate from broader empirics once confirmed.
  • MSSA monomicrobial: cefazolin / nafcillin + clindamycin.
  • MRSA: vancomycin + clindamycin.
  • Polymicrobial (Type I): pip-tazo (or carbapenem) + vanc until MRSA / GAS excluded; continue clinda if GAS / strep grown.
  • Vibrio: doxycycline + ceftriaxone × 1–2 weeks after source control.
  • Clostridial myonecrosis: PCN-G + clindamycin × 10–14 days after debridement.

Duration: 2–3 weeks total typically — extended for retained necrotic tissue, abscess, or bacteremia. Step down once stable + source-controlled.

5. Monitoring

Resolution: clinical stability, lactate / SBP, organ function. Plan for repeat OR every 24–48 h until debridement shows healthy tissue at the margins.

Markers: WBC, lactate, CK (rhabdomyolysis common), Cr, LFTs. Negative-pressure wound therapy / dressings between OR trips.

Toxicity: vanc AUC + Cr q48h; pip-tazo + vanc AKI; clindamycin → CDI risk (don't stop empirically for diarrhea — confirm CDI first; toxin suppression benefit critical).

LRINEC score for risk-stratifying suspected nec fasc (CRP, WBC, hemoglobin, Na, Cr, glucose) — score ≥6 raises suspicion, but a low score does NOT rule out — surgical judgment + clinical suspicion drive decision to operate.

Pearls

Surgical emergency — do not delay debridement for imaging if suspicion is high. Pain out of proportion + rapid progression + systemic toxicity + skin findings late (anesthesia, bullae, dusky skin) → straight to OR. LRINEC score can support suspicion but never rules out. Clindamycin is mandatory in suspected streptococcal / clostridial disease — toxin suppression. Vibrio vulnificus in cirrhotic with saltwater / oyster exposure — doxycycline + ceftriaxone. Fournier gangrene is necrotizing infection of perineum — polymicrobial, urgent urology / general surgery involvement. Don't withhold empiric anti-MRSA + anti-Pseudomonal coverage until cultures back — too risky to assume monomicrobial.

References